Meeting of the Advisory Committee on Infant and Maternal Mortality, 70681-70682 [2023-22509]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices
be sent to Pita Gomez using the contact
information listed above at least 5
business days before the meeting
date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Pita
Gomez using the contact information
listed above at least 10 business days
before the meeting(s) they wish to
attend. Since all in-person meetings will
occur in a federal government building,
attendees must go through a security
check to enter the building. Non-U.S.
Citizen attendees must notify HRSA of
their planned attendance at least 20
business days prior to the meeting to
facilitate their entry into the building.
All attendees are required to present
government-issued identification prior
to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–22584 Filed 10–11–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Heritable Disorders in Newborns and
Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Heritable Disorders in
Newborns and Children (ACHDNC or
Committee) has scheduled a public
meeting to be held on Thursday,
November 2, 2023, and Friday,
November 3, 2023. Information about
the ACHDNC and the agenda for this
meeting can be found on the ACHDNC
website at https://www.hrsa.gov/
advisory-committees/heritabledisorders/.
DATES: Thursday, November 2, 2023,
from 10:00 a.m. to 4:00 p.m. Eastern
Time (ET) and Friday, November 3,
2023, from 10:00 a.m. to 2:00 p.m. ET.
ADDRESSES: This meeting will be held
via webinar. While this meeting is open
to the public, advance registration is
required.
Please visit the ACHDNC website for
information on registration: https://
www.hrsa.gov/advisory-committees/
heritable-disorders/ by the
deadline of 12:00 p.m. ET on November
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:34 Oct 11, 2023
Jkt 262001
1, 2023. Instructions on how to access
the meeting via webcast will be
provided upon registration.
FOR FURTHER INFORMATION CONTACT:
Alaina Harris, Maternal and Child
Health Bureau, HRSA, 5600 Fishers
Lane, Room 18W66, Rockville,
Maryland 20857; 301–443–0721; or
ACHDNC@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACHDNC
provides advice and recommendations
to the Secretary of Health and Human
Services (Secretary) on the development
of newborn screening activities,
technologies, policies, guidelines, and
programs for effectively reducing
morbidity and mortality in newborns
and children having, or at risk for,
heritable disorders. ACHDNC reviews
and reports regularly on newborn and
childhood screening practices,
recommends improvements in the
national newborn and childhood
screening programs, and fulfills
requirements stated in the authorizing
legislation. In addition, ACHDNC’s
recommendations regarding inclusion of
additional conditions for screening on
the Recommended Uniform Screening
Panel, following adoption by the
Secretary, are evidence-informed
preventive health services provided for
in the comprehensive guidelines
supported by HRSA pursuant to section
2713 of the Public Health Service Act
(42 U.S.C. 300gg–13). Under this
provision, non-grandfathered group
health plans and health insurance
issuers offering non-grandfathered
group or individual health insurance are
required to provide insurance coverage
without cost-sharing (a co-payment, coinsurance, or deductible) for preventive
services for plan years (i.e., policy years)
beginning on or after the date that is 1
year from the Secretary’s adoption of the
condition for screening.
During the November 2–3, 2023,
meeting, ACHDNC will hear from
experts in the fields of public health,
medicine, heritable disorders, rare
disorders, and newborn screening.
Agenda items include the following:
(1) An update on the Krabbe disease
expedited evidence review update;
(2) An update on the Duchenne
Muscular Dystrophy evidence review
update;
(3) An update by the ACHDNC
Decision Matrix ad hoc topic group and
potential vote on revisions to the
ACHDNC Decision Matrix;
(4) A presentation and discussion on
the ACHDNC’s conflict of interest
procedures;
(5) Ad hoc topic group updates; and
(6) A possible presentation on the
National Academies of Sciences,
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
70681
Engineering, and Medicine Workshop
on Next Generation Screening.
ACHDNC will not vote on
recommending conditions for inclusion
in the Recommended Uniform
Screening Panel during this meeting;
however, Krabbe disease and Duchenne
Muscular Dystrophy evidence review
updates along with a discussion and a
potential vote on revisions to the
ACHDNC Decision Matrix may inform
such potential future recommendations.
Agenda items are subject to change as
priorities dictate. Information about
ACHDNC, including a roster of members
and past meeting summaries, is
available on the ACHDNC website.
Members of the public will have the
opportunity to provide comments on
any or all of the above agenda items.
Public participants may request to
provide general oral comments and may
submit written statements in advance of
the scheduled meeting. Oral comments
will be honored in the order they are
requested and may be limited as time
allows. Members of the public registered
to provide oral public comments on all
other newborn screening related topics
are tentatively scheduled to provide
their statements on Thursday,
November 2, 2023. Requests to provide
a written statement or make oral
comments to ACHDNC must be
submitted via the registration website by
12:00 p.m. ET on Friday, October 20,
2023. Written comments will be shared
with the Committee, so that they have
an opportunity to consider them prior to
the meeting.
Individuals who need special
assistance or another reasonable
accommodation should notify Alaina
Harris at the address and phone number
listed above at least 10 business days
prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–22493 Filed 10–11–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Infant and Maternal Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
SUMMARY:
E:\FR\FM\12OCN1.SGM
12OCN1
ddrumheller on DSK120RN23PROD with NOTICES1
70682
Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices
Committee on Infant and Maternal
Mortality (ACIMM) has scheduled a
public meeting. Information about
ACIMM and the agenda for this meeting
can be found on the ACIMM website at
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
DATES: December 5, 2023, 10 a.m. to 5
p.m. Eastern Time and December 6,
2023, 9:30 a.m. to 2 p.m. Eastern Time.
ADDRESSES: This meeting will be held in
person at HRSA Headquarters (5600
Fishers Lane, Room 5W07, Rockville,
MD, 20857) and virtually via webinar.
The webinar link and log-in information
will be available at the ACIMM website
before the meeting: https://
www.hrsa.gov/advisory-committees/
infant-mortality/.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health
Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, MD 20857;
301–443–0543; or SACIM@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACIMM is
authorized by section 222 of the Public
Health Service Act (42 U.S.C. 217a), as
amended. The Committee is governed
by provisions of the Federal Advisory
Committee Act (5 U.S.C. Chapter 10), as
amended.
ACIMM advises the Secretary of
Health and Human Services (Secretary)
on department activities, partnerships,
policies, and programs directed at
reducing infant mortality, maternal
mortality, and severe maternal
morbidity, and improving the health
status of infants and women before,
during, and after pregnancy. The
Committee provides advice on how to
coordinate federal, state, local, tribal,
and territorial governmental efforts
designed to improve infant mortality,
related adverse birth outcomes,
maternal health, as well as influence
similar efforts in the private and
voluntary sectors. The Committee
provides guidance and
recommendations on the policies,
programs, and resources required to
address the disparities and inequities in
infant mortality, related adverse birth
outcomes and maternal health
outcomes, including maternal mortality
and severe maternal morbidity. With its
focus on underlying causes of the
disparities and inequities seen in birth
outcomes for women and infants, the
Committee advises the Secretary on the
health, social, economic, and
environmental factors contributing to
the inequities and proposes structural,
policy, and/or systems level changes.
The agenda for the December 5–6,
2023, meeting is being finalized and
may include the following topics: an
VerDate Sep<11>2014
17:34 Oct 11, 2023
Jkt 262001
update on the recommendations
submitted to the Secretary on improving
birth outcomes among American Indian/
Alaska Native mothers and infants;
updates on the federal Healthy Start
program; Committee workgroup
discussions on rural health/systems
issues, social determinants of health,
and preconception/interconception care
and reproductive health; federal
updates; and Committee operations.
Agenda items are subject to change as
priorities dictate. Refer to the ACIMM
website listed above for any updated
information concerning the meeting.
Members of the public will have the
opportunity to provide written or oral
comments. Requests to submit a written
statement or make oral comments to
ACIMM should be sent to Vanessa Lee,
using the email address above at least 3
business days prior to the meeting.
Public participants may submit written
statements in advance of the scheduled
meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the
order they are requested and may be
limited as time allows.
Individuals who plan to attend and
need special assistance or a reasonable
accommodation should notify Vanessa
Lee at the contact information listed
above at least 10 business days prior to
the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–22509 Filed 10–11–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2023–0002; Internal
Agency Docket No. FEMA–B–2376]
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
SUMMARY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Management Agency (FEMA) for each
community, is appropriate because of
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
DATES:
The affected communities
are listed in the table below. Revised
flood hazard information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
Submit comments and/or appeals to
the Chief Executive Officer of the
community as listed in the table below.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Mapping and Insurance
eXchange (FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
ADDRESSES:
The
specific flood hazard determinations are
not described for each community in
this notice. However, the online
location and local community map
repository address where the flood
hazard determination information is
available for inspection is provided.
Any request for reconsideration of
flood hazard determinations must be
submitted to the Chief Executive Officer
SUPPLEMENTARY INFORMATION:
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 88, Number 196 (Thursday, October 12, 2023)]
[Notices]
[Pages 70681-70682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22509]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant and Maternal
Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory
[[Page 70682]]
Committee on Infant and Maternal Mortality (ACIMM) has scheduled a
public meeting. Information about ACIMM and the agenda for this meeting
can be found on the ACIMM website at https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: December 5, 2023, 10 a.m. to 5 p.m. Eastern Time and December 6,
2023, 9:30 a.m. to 2 p.m. Eastern Time.
ADDRESSES: This meeting will be held in person at HRSA Headquarters
(5600 Fishers Lane, Room 5W07, Rockville, MD, 20857) and virtually via
webinar. The webinar link and log-in information will be available at
the ACIMM website before the meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Designated Federal
Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane,
Room 18N84, Rockville, MD 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION: ACIMM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of the Federal Advisory Committee Act (5
U.S.C. Chapter 10), as amended.
ACIMM advises the Secretary of Health and Human Services
(Secretary) on department activities, partnerships, policies, and
programs directed at reducing infant mortality, maternal mortality, and
severe maternal morbidity, and improving the health status of infants
and women before, during, and after pregnancy. The Committee provides
advice on how to coordinate federal, state, local, tribal, and
territorial governmental efforts designed to improve infant mortality,
related adverse birth outcomes, maternal health, as well as influence
similar efforts in the private and voluntary sectors. The Committee
provides guidance and recommendations on the policies, programs, and
resources required to address the disparities and inequities in infant
mortality, related adverse birth outcomes and maternal health outcomes,
including maternal mortality and severe maternal morbidity. With its
focus on underlying causes of the disparities and inequities seen in
birth outcomes for women and infants, the Committee advises the
Secretary on the health, social, economic, and environmental factors
contributing to the inequities and proposes structural, policy, and/or
systems level changes.
The agenda for the December 5-6, 2023, meeting is being finalized
and may include the following topics: an update on the recommendations
submitted to the Secretary on improving birth outcomes among American
Indian/Alaska Native mothers and infants; updates on the federal
Healthy Start program; Committee workgroup discussions on rural health/
systems issues, social determinants of health, and preconception/
interconception care and reproductive health; federal updates; and
Committee operations. Agenda items are subject to change as priorities
dictate. Refer to the ACIMM website listed above for any updated
information concerning the meeting.
Members of the public will have the opportunity to provide written
or oral comments. Requests to submit a written statement or make oral
comments to ACIMM should be sent to Vanessa Lee, using the email
address above at least 3 business days prior to the meeting. Public
participants may submit written statements in advance of the scheduled
meeting by emailing [email protected]. Oral comments will be honored in
the order they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or a
reasonable accommodation should notify Vanessa Lee at the contact
information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-22509 Filed 10-11-23; 8:45 am]
BILLING CODE 4165-15-P
